Moderna, Inc.
- MRNA
- NASDAQ
- Biotechnology
- mRNA Therapeutics/Vaccines
$218.01
Today −7.82%Quote Oct 16, 2026, 08:00 PM UTC
+37.92%over the last month
Max drawdown −7.9%From 1-month high −7.8%3 months +266.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$87.04B
Quote Oct 16
Next earnings
Nov 6
Expected, not confirmed
Analyst target
$117.40
−46.1% from here
Floor
$210.83
3.3% below price
Where the price sits
29 analysts
Analyst range, low to high
$25.00$245.00
- Price $218.01
- Resistance $226.45–$228.72
- Consensus $117.40
Analysts' average target sits about 46% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MRNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
4,700
Founded
2010